About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
F
Altering the Mitochondrial Potential as a Therapeutic Approach in B-cell Lymphoma
By
Francisco Hernandez-Ilizaliturri
May 7, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Scripps MD Anderson Cancer Center
Scripps MD Anderson Cancer Center's Clinical Hematology & Oncology 2021
Sat, Feb 20, 2021
The Royal Marsden School
Demystifying the Science Behind Targeted Treatments for Haematological C...
Tue, Feb 2, 2021
Total Health Conferencing
Virtual West Oncology Conference
Fri, Feb 26, 2021
21:22
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018- Aggressive Lymphomas: Recent Approvals and Promising ...
Feat.
A. Vallurupalli
21:22
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
Feat.
D. LeRoith
13:30
Helen Heslop
CAR T-cell Therapy for Hematologic Malignancies Other Than CD19
32:01
Seattle Cancer Care Alliance
CAR-T Cell Therapy - Patient Eligibility for Clinical Trials vs. Commerc...
Feat.
D. Maloney
22:18
2018 Pan Pacific Lymphoma Conference
Medical Cannabis
Feat.
S. Kurtin
43:39
Leonard Calabrese
T-cell Activation, Deactivation and Control and the Impact of Cancer Imm...
08:13
CancerGRACE
2020 Update on Blood Cancer Diagnosis: Morphology, Cytogenetic/Molecular...
Feat.
M. Ruiz
08:39
CancerGRACE
2020 Update Blood Cancers: IO vs. Chemo, Targeted Therapies, Bone Marrow...
Feat.
M. Ruiz
06:51
CancerGRACE
2020 Update on the Prevalence & Epidemiology of Blood Cancers: Aggressiv...
Feat.
M. Ruiz
47:35
Vanderbilt University Medical Center (VUMC)
Diagnosis of Bone Tumors: Presentation, Indications, Staging, Metastasis
Feat.
G. Holt
09:17
Vanderbilt University Medical Center (VUMC)
Common Orthopaedic Oncology Pathology: Soft Tissue Sarcomas and Giant Ce...
Feat.
G. Holt
33:15
Vanderbilt University Medical Center (VUMC)
Radiographic Assessment of Bone Tumors: Location, Tumor-Bone Interaction...
Feat.
G. Holt
32:37
Vanderbilt University Medical Center (VUMC)
Metastatic Bone Disease: How to Perfrom a General Evaluation? Bone Lesio...
Feat.
G. Holt
33:11
Vanderbilt University Medical Center (VUMC)
Common Orthopaedic Oncology Pathology: Osteosarcoma, Chondrosarcoma, Ewi...
Feat.
G. Holt
30:30
Boston Scientific
Dosimetry Series: Radiation Lobectomy
Feat.
R. Lewandowski
59:58
Boston Scientific
The Evolution of Dosimetry Using Y-90 Glass Microspheres
Feat.
S. Young,
R. Salem,
R. Lewandowski,
J. Gimenez
10:27
Peter Reichardt
2020 Update on GIST Local Treatment Options: How Effective and Safe Are ...
12:23
Vanderbilt University Medical Center (VUMC)
Common Orthopaedic Oncology Pathology: Metastatic Bone Disease
Feat.
G. Holt
15:11
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Fitness in CLL: What Is the Role of Comorbiditie...
Feat.
A. Tedeschi
02:18
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: How it’s Made